Merit Medical Systems Beheer
Beheer criteriumcontroles 3/4
De CEO Merit Medical Systems is Fred Lampropoulos, benoemd in Jul1987, heeft een ambtstermijn van 37.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 10.05M, bestaande uit 18.8% salaris en 81.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.97% van de aandelen van het bedrijf, ter waarde $ 113.62M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.2 jaar en 4.8 jaar.
Belangrijke informatie
Fred Lampropoulos
Algemeen directeur
US$10.1m
Totale compensatie
| Percentage CEO-salaris | 18.8% |
| Dienstverband CEO | 37.3yrs |
| Eigendom CEO | 2.0% |
| Management gemiddelde ambtstermijn | 5.2yrs |
| Gemiddelde ambtstermijn bestuur | 4.8yrs |
Recente managementupdates
Recent updates
Merit Medical Systems, Inc. (NASDAQ:MMSI) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 02
Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Nov 01Merit Medical Systems - Impressive Momentum
Sep 17The Price Is Right For Merit Medical Systems, Inc. (NASDAQ:MMSI)
Sep 17Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching
Sep 04Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
Aug 22These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Jul 31Merit Medical Systems: Steady Wins The Day
Jul 05Merit Medical Systems (NASDAQ:MMSI) Ticks All The Boxes When It Comes To Earnings Growth
Jun 19Merit Medical: Undervalued With Multiple Growth Drivers In Play
Jun 15Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
May 23It Looks Like Shareholders Would Probably Approve Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Compensation Package
May 09Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Is Merit Medical Systems (NASDAQ:MMSI) Using Too Much Debt?
Apr 30Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing
Apr 16When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Apr 02Merit Medical Systems: Solid Performer, Fully Valued
Mar 03Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report
Mar 02We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease
Feb 05The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing
Jan 23What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E
Dec 18These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Nov 21What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?
Nov 06Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
Oct 23Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?
Sep 11Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing
Aug 13Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jul 31Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Jul 17Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Jun 07Is It Time To Consider Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
May 01We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease
Apr 16Returns On Capital At Merit Medical Systems (NASDAQ:MMSI) Have Hit The Brakes
Apr 02Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Mar 01Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Intrinsic Value Is Potentially 24% Below Its Share Price
Feb 01Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jan 12Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly
Dec 29Here's Why We Think Merit Medical Systems (NASDAQ:MMSI) Is Well Worth Watching
Nov 23Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$120m |
| Jun 30 2024 | n/a | n/a | US$117m |
| Mar 31 2024 | n/a | n/a | US$102m |
| Dec 31 2023 | US$10m | US$2m | US$94m |
| Sep 30 2023 | n/a | n/a | US$100m |
| Jun 30 2023 | n/a | n/a | US$90m |
| Mar 31 2023 | n/a | n/a | US$85m |
| Dec 31 2022 | US$8m | US$2m | US$75m |
| Sep 30 2022 | n/a | n/a | US$62m |
| Jun 30 2022 | n/a | n/a | US$58m |
| Mar 31 2022 | n/a | n/a | US$48m |
| Dec 31 2021 | US$8m | US$2m | US$48m |
| Sep 30 2021 | n/a | n/a | US$43m |
| Jun 30 2021 | n/a | n/a | US$28m |
| Mar 31 2021 | n/a | n/a | US$4m |
| Dec 31 2020 | US$8m | US$2m | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$29m |
| Jun 30 2020 | n/a | n/a | -US$30m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | US$5m | US$2m | US$5m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$39m |
| Mar 31 2019 | n/a | n/a | US$43m |
| Dec 31 2018 | US$4m | US$2m | US$42m |
| Sep 30 2018 | n/a | n/a | US$40m |
| Jun 30 2018 | n/a | n/a | US$19m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$4m | US$1m | US$28m |
Compensatie versus markt: De totale vergoeding ($USD 10.05M ) Fred } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 8.06M ).
Compensatie versus inkomsten: De vergoeding van Fred is het afgelopen jaar met meer dan 20% gestegen.
CEO
Fred Lampropoulos (74 yo)
37.3yrs
Tenure
US$10,052,664
Compensatie
Mr. Fred P. Lampropoulos has been the President of BioSphere Medical, Inc. since September 2010. He is Founder of Merit Medical Systems, Inc. and has been its Chairman and Chief Executive Officer since Jul...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 37.3yrs | US$10.05m | 1.97% $ 113.6m | |
| President | less than a year | US$2.81m | 0.060% $ 3.4m | |
| CFO & Treasurer | 6.5yrs | US$2.77m | 0.013% $ 737.0k | |
| Chief Operating Officer | 2.6yrs | US$2.71m | 0.025% $ 1.5m | |
| Chief Legal Officer & Corporate Secretary | 8.6yrs | US$2.66m | 0.030% $ 1.7m | |
| Chief Information Officer | 1.8yrs | geen gegevens | geen gegevens | |
| Vice President of Global Communications | no data | geen gegevens | geen gegevens | |
| Executive Vice President of Global Marketing & Strategy | no data | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | 3.9yrs | geen gegevens | geen gegevens | |
| Chief Regulatory Affairs Officer | 11.8yrs | geen gegevens | geen gegevens | |
| Managing Director of Operation Merit Medical Tijuana | no data | geen gegevens | geen gegevens | |
| Executive Vice President of Merit Medical EMEA | no data | geen gegevens | geen gegevens |
5.2yrs
Gemiddelde duur
55.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van MMSI is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.2 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 37.3yrs | US$10.05m | 1.97% $ 113.6m | |
| Independent Director | 2.5yrs | US$275.99k | 0.0052% $ 301.1k | |
| Lead Independent Director | 9.3yrs | US$320.99k | 0.051% $ 3.0m | |
| Independent Director | 7.5yrs | US$290.99k | 0.029% $ 1.7m | |
| Independent Director | 4.4yrs | US$290.99k | 0.018% $ 1.0m | |
| Independent Director | 5.3yrs | US$295.99k | 0.010% $ 589.0k | |
| Independent Director | 3.4yrs | US$275.99k | 0.0080% $ 463.5k | |
| Independent Director | less than a year | geen gegevens | geen gegevens |
4.8yrs
Gemiddelde duur
63.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van MMSI wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).